Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
CLGN
CLGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CLGN News
CollPlant Reports Q1 2026 Financial Results and Strategic Developments
2d ago
Newsfilter
CollPlant Reports Q1 Earnings Results
2d ago
seekingalpha
CollPlant Reports Q1 2026 Financial Results and Corporate Update
2d ago
PRnewswire
CollPlant Ends AbbVie Partnership, Eyes New Opportunities Ahead
Apr 13 2026
PRnewswire
CollPlant Biotechnologies Reports FY 2025 Financial Results
Mar 26 2026
seekingalpha
CollPlant Reports 2025 Financial Results and Corporate Updates
Mar 26 2026
PRnewswire
CollPlant Faces Nasdaq Delisting Risk Due to Low Share Price
Mar 24 2026
PRnewswire
CollPlant Receives Nasdaq Warning on Share Price
Mar 24 2026
seekingalpha
CollPlant to Report 2025 Financial Results on March 26, 2026
Mar 11 2026
PRnewswire
CollPlant Launches BioFlex Bioink Kit for 3D Bioprinting
Feb 23 2026
PRnewswire
CollPlant Launches BioFlex Bioink for Advanced 3D Bioprinting
Feb 23 2026
Newsfilter
Wall Street Analysts Adjust Ratings on Top Stocks
Feb 06 2026
Benzinga
D. Boral Capital Upholds Buy Rating for CollPlant Biotechnologies (CLGN)
Nov 29 2025
NASDAQ.COM
D. Boral Capital Reiterates Buy Rating for CollPlant Biotechnologies with $12 Price Target Intact
Nov 28 2025
Benzinga
CollPlant Partners with U.S. Logistics Center to Expand North American Market
Nov 26 2025
Newsfilter
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Nov 26 2025
PRnewswire
Show More News
